Halucenex Life Sciences Inc. targets Australian market following landmark TGA decision

/PRNewswire/ -- Creso Pharma Limited (ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its wholly-owned psychedelics subsidiary, Halucenex Life...

Related Keywords

Australia ,Canada ,Switzerland ,Steinhausen ,Switzerland General ,Nedlands ,Western Australia ,Australian ,Creso Pharma ,Halucenex Life Sciences Inc ,Creso Pharma Limited ,Therapeutic Goods Administration ,Pharma Limited ,Life Sciences ,Australian Government ,Nova Scotia ,Psilocybin Supplier ,Health Canada ,Special Access ,Managing Director William ,Good Manufacturing Practice ,Looking Statements ,